William Kane Net Worth

William Kane biography

William J. Kane serves as Independent Director of the Company. Mr. Kane has served as a director of LMB and, upon LMB’s acquisition by the Company in March 2016, a director of the Company. He has served as a Clinical Professor at Duke University Medical Center since 2003. From 2006 to 2009, he served as the Chief Executive Officer of Radar Find Corporation, and from 2002 to 2003, he served as the Interim Chief Medical Officer of Mercy Fitzgerald Hospital. From 1996 until 2002, Dr. Kane served as the President and Chief Executive Officer of InteCardia, Inc., and from 1995 until 1996, he was with Health Care Consultant. From 1993 to 1995, Dr. Kane served in various capacities at Sharp Healthcare including Executive Vice President, Operations and Executive Vice President, Community Care. From 1992 to 1993, he was the Senior Vice President, Medical Affairs at Independence Blue Cross, and from 1990 to 1992, he served in various capacities at Centra State Medical Center including President, Chief Executive Officer, Executive Vice President and Chief Operating Officer. From 1989 to 1990, Dr. Kane was with Cain Brothers, Shattuck & Co., and from 1988 to 1989, he was the Senior Vice President, Health Services Division of American International Healthcare (formerly JBI). From 1986 to 1987, Dr. Kane was the Executive Vice President and Corporate Medical Director of CIGNA Healthplan, Inc. and from 1984 to 1986, he was at U.S. Healthcare, Inc. and served in various capacities including Senior Vice President Medical Delivery, President and Senior Medical Director. Dr. Kane is currently the chair of the board of directors of Research Triangle Park and was a past member of the board of directors of Pisacano Leadership Foundation and Make-A-Wish Foundation. In addition, he previously served on the Management Advisory Committee of Cornucopia House Cancer Support Center. Dr. Kane received his B.S. in Biology from the University of Scranton and his M.D. with Honors from the Temple University School of Medicine.

How old is William Kane?

William Kane is 76, he's been the Independent Director of Citius Pharmaceuticals Inc since 2016. There are 1 older and 11 younger executives at Citius Pharmaceuticals Inc. The oldest executive at Citius Pharmaceuticals Inc is Suren Dutia, 77, who is the Independent Director.

What's William Kane's mailing address?

William's mailing address filed with the SEC is C/O CITIUS PHARMACEUTICALS, INC., 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016.

Insiders trading at Citius Pharmaceuticals Inc

Over the last 9 years, insiders at Citius Pharmaceuticals Inc have traded over $0 worth of Citius Pharmaceuticals Inc stock and bought 13,825,289 units worth $15,819,221 . The most active insiders traders include Leonard L Mazur, Myron Z Holubiak, and Dennis M Mcgrath. On average, Citius Pharmaceuticals Inc executives and independent directors trade stock every 207 days with the average trade being worth of $523,934. The most recent stock trade was executed by Eugene Myron Holuka on 13 March 2024, trading 2,415 units of CTXR stock currently worth $48.

What does Citius Pharmaceuticals Inc do?

citius pharmaceuticals, inc., a specialty pharmaceutical company, develops and commercializes critical care products. it primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. the company is developing mino-lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in phase iii clinical trials; mino-wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; halo-lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and novecite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. citius pharmaceuticals, inc. was founded in 2007 and is headquartered in cranford, new jersey.

Citius Pharmaceuticals Inc executives and stock owners

Citius Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Myron Z. Holubiak,
  Pres, CEO & Director
• Myron Holubiak,
  President, Chief Executive Officer, Director
• Leonard L. Mazur,
  Exec. Chairman & Sec.
• Dr. Myron S. Czuczman M.D.,
  Exec. VP & Chief Medical Officer
• Jaime Bartushak,
  Chief Financial Officer, Principal Financial Officer
• Jaime Bartushak,
  CFO & Chief Accounting Officer
• Leonard Mazur,
  Executive Chairman of the Board, Secretary
• Carol Webb,
  Independent Director
• Howard Safir,
  Independent Director
• William Kane,
  Independent Director
• Eugene Holuka,
  Independent Director
• Suren Dutia,
  Independent Director
• Kelly Creighton Ph.D.,
  Exec. VP of Chemistry, Manufacturing & Controls
• Dhananjay G. Wadekar,
  Sr. VP of Bus. Strategy
• Ilanit Allen,
  VP of Investor Relations
• Gary F. Talarico,
  Exec. VP of Operations
• Myron Czuczman,
  Chief Medical Officer
• Robert Joseph Smith,
  Director
• Dennis M Mcgrath,
  Director